Related Experiment Video

Updated: Jun 12, 2025

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

[Pulmonary hypertension associated with chronic lung diseas]

Élise Noël-Savina¹, Ségolène Turquier², Ari Chaouat³

¹Service de pneumologie et de soins intensifs respiratoires, CHU Toulouse, centre de compétence de l'hypertension pulmonaire (PulmoTension), hôpital Larrey, Toulouse, France.

La Revue Du Praticien

|June 6, 2025

Summary

Pulmonary hypertension frequently complicates chronic lung diseases, impacting survival and quality of life. Diagnosis requires right heart catheterization, with severe cases defined by high pulmonary vascular resistance, necessitating specialized treatment.

Area of Science:

Cardiology
Pulmonology
Respiratory Medicine

Background:

Pulmonary hypertension (PH) is a common complication of chronic lung diseases.
It significantly reduces patient quality of life and short- to medium-term survival.
Chronic lung diseases represent a major cause of secondary pulmonary hypertension.

Purpose of the Study:

To highlight the association between chronic lung diseases and pulmonary hypertension.
To define diagnostic criteria and severity assessment for PH in this context.
To emphasize the importance of specialized centers for treatment decisions.

Main Methods:

Diagnosis of PH relies on right heart catheterization.
Assessment of pulmonary vascular resistance (PVR) is crucial.
Severity is classified based on PVR values.

Main Results:

Pulmonary hypertension is prevalent in patients with chronic respiratory conditions.
Severe PH is defined as PVR exceeding 5 Wood units.
Right heart catheterization is the gold standard for diagnosis.

Conclusions:

Chronic lung disease-associated PH negatively affects patient outcomes.
Accurate diagnosis via right heart catheterization is essential.
Treatment for severe PH (PVR > 5 Wood units) should be managed in specialized pulmonary hypertension centers.

Keywords:

Hypertension, Pulmonary Respiratory Tract Diseases

More Related Videos

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

Articles linked to this work by shared authors, journal, and citation graph.

Plasma KL-6 reflects pulmonary severity and longitudinal response to enzyme replacement therapy in acid sphingomyelinase deficiency type B.

Molecular genetics and metabolism reports·2026

Pulmonary diffusion abnormalities in patients with inflammatory bowel disease: A longitudinal study.

Therapeutic advances in gastroenterology·2026

Pulmonary vascular complications following lung transplantation: characteristics, incidence, survival.

Respiratory medicine and research·2026

Long-term efficacy and safety of rehabilitation in patients with pulmonary arterial hypertension: the FONCE-HTAP randomized controlled trial.

Annals of the American Thoracic Society·2026

Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis.

Respiratory medicine and research·2026

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry.

The European respiratory journal·2026

See all related articles